Neuro-oncology: oligodendroglioma and molecular markers.
Stupp
Roger
R
Multidisciplinary Oncology Centre and Laboratory of Tumor Biology and Genetics, Department of Neurosurgery, University of Lausanne Hospitals, 1011 Lausanne, Switzerland. roger.stupp@chuv.ch
Hegi
Monika E
ME
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D002875:Chromosomes; D018773:Genes, erbB-1 / Q000235:genetics; D005819:Genetic Markers; D005909:Glioblastoma / Q000235:genetics; D006801:Humans; D009837:Oligodendroglioma / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D011379:Prognosis; D013234:Stem Cells / Q000502:physiology; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D005819:Genetic Markers